USPTO serial 79432124
OSLER
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- MESSICK, TABITHA LEE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with OSLER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Assays and reagents for scientific or medical research purposes. | ACTIVE | — |
| 005 | medical preparations, namely, diagnostic reagents for in vitro use in haematology, biochemistry, clinical chemistry and microbiology for medical purposes; chemical preparations, namely, diagnostic assays and reagents for diagnostic testing for medical purposes; diagnostic preparations, substances, agents, reagents, assays and materials for medical purposes; diagnostic testing preparations, substances, agents, reagents, assays and materials for medical purposes, namely, for the testing of blood, body fluids, blood derivatives and body fluid derivatives. | ACTIVE | — |
| 009 | Scientific apparatus and instruments, namely, analysers and cartridges for laboratory use for testing chemical, biological and environmental samples for scientific or clinical research purposes; scientific research and laboratory apparatus and instruments, namely, analysers and cartridges for laboratory use for haematology, biochemistry, clinical chemistry and microbiology testing; scientific research and laboratory apparatus and instruments, namely, diagnostic devices for the analysis of blood, body fluids, blood derivatives and body fluid derivatives for scientific or clinical research purposes; scientific research and laboratory apparatus and instruments, namely, devices for collecting, storing, processing, transferring, testing, analysing and monitoring liquid samples of blood, body fluids, blood derivatives and body fluid derivatives and for reporting in relation to the same; scientific research and laboratory apparatus and instruments, namely, diagnostic devices for detecting pathogens and biomarkers in liquid samples, blood, body fluids, blood derivatives and body fluid derivatives and for reporting in relation to the same; scientific research and laboratory apparatus and instruments, namely, blood testing apparatus for scientific or clinical research purposes; scientific research and laboratory apparatus and instruments, namely, apparatus for blood analysis for scientific or clinical research purposes; material testing apparatus and instruments, namely, diagnostic testing apparatus and instruments for the detection and measurement of clinical biomarkers in blood and bodily fluids for scientific or clinical research use; monitoring, measuring, signalling and control apparatus and instruments, namely, signal measuring instruments for use in electrochemical analysis, potentiostats, galvanostats and impedance analysers; computer apparatus and instruments, namely, computer hardware and peripheral apparatus for clinical research or scientific purposes; downloadable software for analysing data obtained from blood, body fluids, blood derivatives and body fluid derivatives and downloadable software for operating analytical and diagnostic devices; downloadable application software for management of patient data, healthcare workflow and connectivity between patients and healthcare providers; computer hardware for data capture, collection, recording, processing, transmission, reproduction, storage and communications; structural parts and fittings for all the aforementioned goods. | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, analysers and cartridges for haematology, biochemistry, clinical chemistry and microbiology testing; medical apparatus and instruments, namely, diagnostic devices for the analysis of blood, body fluids, blood derivatives and body fluid derivatives; medical apparatus and instruments, namely, devices for collecting, storing, processing, transferring, testing, analysing and monitoring liquid samples of blood, body fluids, blood derivatives and body fluid derivatives, and for reporting in relation to the same; medical apparatus and instruments, namely, wearable devices with sensors for monitoring patient vital signs, blood and sweat properties and physical movement; medical diagnostic apparatus and instruments, namely, diagnostic devices for detecting and measuring pathogens and biomarkers in blood, body fluids, blood derivatives and body fluid derivatives, and for reporting in relation to the same; medical diagnostic apparatus and instruments, namely, analysers and cartridges for use in diagnosing and monitoring acute and chronic diseases, infectious diseases, hereditary diseases, dietary and metabolic deficiency disorders, and physiological disorders; blood testing apparatus and instruments for medical and medical diagnostic purposes, namely, electrochemical biosensors for the determination of concentrations of target analytes in body fluids for medical purposes; testing apparatus and instruments for medical and medical diagnostic purposes, namely, electronic measuring instruments for medical use for the analysis of samples of blood, body fluids, blood derivatives and body fluid derivatives; medical diagnostic testing apparatus and instruments for the measurement of clinical bio markers; structural parts and fittings for all the aforementioned goods. | ACTIVE | — |
| 044 | Medical services; medical diagnostic services; medical testing, screening and analysis services relating to the diagnosis and/or treatment of disease; consultancy, advisory and information services relating to or connected with the aforementioned services. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Osler Diagnostics Limited
- Other trademarks owned by Osler Diagnostics Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named OSLER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 18, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 18, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 12, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 24, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 17, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 17, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 17, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 28, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 28, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 28, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 28, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 12, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 19, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 19, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 14, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 13, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 12, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 8, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 8, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 4, 2025 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |